Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.3.1819

Analysis of Key Genes and Pathways Associated with Colorectal Cancer with Microarray Technology  

Liu, Yan-Jun (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University)
Zhang, Shu (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University)
Hou, Kang (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University)
Li, Yun-Tao (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University)
Liu, Zhan (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University)
Ren, Hai-Liang (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University)
Luo, Dan (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University)
Li, Shi-Hong (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.3, 2013 , pp. 1819-1823 More about this Journal
Abstract
Objective: Microarray data were analyzed to explore key genes and their functions in progression of colorectal cancer (CRC). Methods: Two microarray data sets were downloaded from Gene Expression Omnibus (GEO) database and differentially expressed genes (DEGs) were identified using corresponding packages of R. Functional enrichment analysis was performed with DAVID tools to uncover their biological functions. Results: 631 and 590 DEGs were obtained from the two data sets, respectively. A total of 32 common DEGs were then screened out with the rank product method. The significantly enriched GO terms included inflammatory response, response to wounding and response to drugs. Two interleukin-related domains were revealed in the domain analysis. KEGG pathway enrichment analysis showed that the PPAR signaling pathway and the renin-angiotensin system were enriched in the DEGs. Conclusions: Our study to systemically characterize gene expression changes in CRC with microarray technology revealed changes in a range of key genes, pathways and function modules. Their utility in diagnosis and treatment now require exploration.
Keywords
Colorectal cancer; differentially expressed genes; microarray; pathway; functional enrichment analysis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Talseth-Palmer BA, McPhillips M, Groombridge C, et al (2010). MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer. Hered Cancer Clin Pract, 8, 5.   DOI   ScienceOn
2 Todaro M, Francipane MG, Medema JP, Stassi G (2010). Colon cancer stem cells: promise of targeted therapy. Gastroenterology, 138, 2151-62.   DOI   ScienceOn
3 Wood LD, Calhoun ES, Silliman N, et al (2006). Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. Hum Mutat, 27, 1060-1.
4 Xi HQ, Zhao P (2011). Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. J Clin Pathol, 64, 498-503.   DOI   ScienceOn
5 Yang WL, Frucht H (2001). Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis, 22, 1379-83.   DOI   ScienceOn
6 Zhai XH, Yu JK, Yang FQ, Zheng S (2012). Identification of a new protein biomarker for colorectal cancer diagnosis. Mol Med Report, 6, 444-8.
7 Ager EI, Neo J, Christophi C (2008). The renin-angiotensin system and malignancy. Carcinogenesis, 29, 1675-84.   DOI   ScienceOn
8 Aizat AA, Shahpudin SN, Mustapha MA, et al (2011). Association of Arg72Pro of P53 polymorphism with colorectal cancer susceptibility risk in Malaysian population. Asian Pac J Cancer Prev, 12, 2909-13.
9 Amid A, Wan Chik WD, Jamal P, Hashim YZ (2012). Microarray and quantitative PCR analysis of gene expression profiles in response to treatment with tomato leaf extract in mcf-7 breast cancer cells. Asian Pac J Cancer Prev, 13, 6319-25.   과학기술학회마을   DOI   ScienceOn
10 Ansel KM, Harris RB, Cyster JG (2002). CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity, 16, 67-76.   DOI   ScienceOn
11 Bernardi CC, Ribeiro Ede S, Cavalli IJ, et al (2010). Amplification and deletion of the ACHE and BCHE cholinesterase genes in sporadic breast cancer. Cancer Genet Cytogenet, 197, 158-65.   DOI   ScienceOn
12 Bigler J, Whitton J, Lampe JW, et al (2001). CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res, 61, 3566-9.
13 Brass N, Racz A, Heckel D, et al (1997). Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung. Cancer Res, 57, 2290-4.
14 Burrell LM, Johnston CI, Tikellis C, Cooper ME (2004). ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol Metab, 15, 166-9.   DOI   ScienceOn
15 Davies H, Hunter C, Smith R, et al (2005). Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res, 65, 7591-5.
16 de Wit M, Fijneman RJ, Verheul HM, et al (2012). Proteomics in colorectal cancer translational research: Biomarker discovery for clinical applications. Clin Biochem, 46, 466-79.
17 Dong P, He XW, Gu J, et al (2011). Vimentin significantly promoted gallbladder carcinoma metastasis. Chin Med J Beijing, 124, 4236.
18 Doniger SW, Salomonis N, Dahlquist KD, et al (2003). MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol, 4, R7.   DOI
19 Draghici S, Khatri P, Tarca AL, et al (2007). A systems biology approach for pathway level analysis. Genome Res, 17, 1537-45.   DOI   ScienceOn
20 Edgar R, Domrachev M, Lash AE (2002). Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res, 30, 207-10.   DOI   ScienceOn
21 El-Haibi CP, Singh R, Sharma PK, et al (2011). CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation. Cell Prolif, 44, 311-9.   DOI   ScienceOn
22 Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.   DOI   ScienceOn
23 Garber K (2010). Of Ephs and ephrins: companies target guidance molecules in cancer. J Natl Cancer Inst, 102, 1692-4.   DOI   ScienceOn
24 George AJ, Thomas WG, Hannan RD (2010). The reninangiotensin system and cancer: old dog, new tricks. Nat Rev Cancer, 10, 745-59.   DOI   ScienceOn
25 Greystoke A, Dean E, Saunders MP, et al (2012). Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer. Br J Cancer, 107, 1518-24.   DOI   ScienceOn
26 Hong F, Breitling R, McEntee CW, et al (2006). RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics, 22, 2825-7.   DOI   ScienceOn
27 Hong Y, Ho KS, Eu KW, Cheah PY (2007). A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis. Clin Cancer Res, 13, 1107-14.   DOI   ScienceOn
28 Huang da W, Sherman BT, Lempicki RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4, 44-57.
29 Hubner RA, Muir KR, Liu JF, et al (2006). Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence. Clin Cancer Res, 12, 6585-9.   DOI   ScienceOn
30 Hunter S, Apweiler R, Attwood TK, et al (2009). InterPro: the integrative protein signature database. Nucleic Acids Res, 37, D211-5.   DOI   ScienceOn
31 Johnson V, Lipton LR, Cummings C, et al (2005). Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families. J Med Genet, 42, 756-62.   DOI   ScienceOn
32 Koizumi K, Kozawa Y, Ohashi Y, et al (2007). CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro. Oncol Rep, 17, 1511-6.
33 Lisabeth EM, Fernandez C, Pasquale EB (2012). Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms. Biochemistry, 51, 1464-75.   DOI   ScienceOn
34 Liu N, Fang XD, Vadis Q (2012). CD73 as a novel prognostic biomarker for human colorectal cancer. J Surg Oncol, 106, 918-9; author reply 920.   DOI   ScienceOn
35 Lokshin AE, Winans M, Landsittel D, et al (2006). Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer. Gynecol Oncol, 102, 244-51.   DOI   ScienceOn
36 Marx J (2004). Cancer research. Inflammation and cancer: the link grows stronger. Science, 306, 966-8.   DOI   ScienceOn
37 Meng W, Zhu HH, Xu ZF, et al (2012). Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening. World J Gastrointest Oncol, 4, 145-51.   DOI   ScienceOn
38 Menin C, Scaini MC, De Salvo GL, et al (2006). Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. J Natl Cancer Inst, 98, 285-8.   DOI   ScienceOn
39 Montenegro MF, Ruiz-Espejo F, Campoy FJ, et al (2006). Acetyland butyrylcholinesterase activities decrease in human colon adenocarcinoma. J Mol Neurosci, 30, 51-4.   DOI   ScienceOn
40 Pan D, Sun N, Cheung KH, et al (2003). PathMAPA: a tool for displaying gene expression and performing statistical tests on metabolic pathways at multiple levels for Arabidopsis. BMC bioinformatics, 4, 56.   DOI   ScienceOn
41 Panse J, Friedrichs K, Marx A, et al (2008). Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients. Br J Cancer, 99, 930-8.   DOI   ScienceOn
42 Pasquale EB (2010). Eph receptors and ephrins in cancer:bidirectional signalling and beyond. Nat Rev Cancer, 10, 165-80.   DOI   ScienceOn
43 Ricci-Vitiani L, Fabrizi E, Palio E, De Maria R (2009). Colon cancer stem cells. J Mol Med (Berl), 87, 1097-104.   DOI   ScienceOn
44 Rubie C, Frick VO, Pfeil S, et al (2007). Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J Gastroenterol, 13, 4996-5002.
45 Sabates-Bellver J, Van der Flier LG, de Palo M, et al (2007). Transcriptome profile of human colorectal adenomas. Mol Cancer Res, 5, 1263-75.   DOI   ScienceOn
46 Samowitz WS, Wolff RK, Curtin K, et al (2006). Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Clin Gastroenterol Hepatol, 4, 894-901.   DOI   ScienceOn
47 Shields JD, Kourtis IC, Tomei AA, et al (2010). Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science, 328, 749-52.   DOI   ScienceOn
48 Singh S, Singh R, Sharma PK, et al (2009). Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Cancer Lett, 283, 29-35.   DOI   ScienceOn
49 Smyth GK (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol, 3, Article3.
50 Surawska H, Ma PC, Salgia R (2004). The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev, 15, 419-33.   DOI   ScienceOn
51 Takahashi M, Cuatrecasas M, Balaguer F, et al (2012). The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. PLoS One, 7, e46684.   DOI
52 Takahashi N, Goto T, Kusudo T, et al (2005). [The structures and functions of peroxisome proliferator-activated receptors (PPARs)]. Nihon Rinsho, 63, 557-64.